The Medical Letter on Drugs and Therapeutics
Minimed 670G: A Hybrid Closed-Loop Insulin Delivery System
November 21, 2016 (Issue: 1508)The FDA has approved the Minimed 670G (Medtronic), a hybrid closed-loop insulin delivery system for use in patients ≥14 years old with type 1 diabetes. The system uses an algorithm to automatically adjust basal insulin doses based on readings...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.